Literature DB >> 6359913

Preoperative antibiotics for abdominal gunshot wounds. A prospective, randomized study.

F A Moore, E E Moore, M R Mill.   

Abstract

In an effort to define the optimal preventive antibiotics for gunshot wounds to the abdomen, 100 consecutive patients were randomized while in the emergency department to receive either combination ampicillin, amikacin, and clindamycin, combination doxycycline and penicillin, or carbenicillin (Groups I, II, and III, respectively). Antibiotics were continued for 5 days in the presence of distal ileal or colonic injury. The study groups were comparable in age, sex, incidence of shock, degree of peritoneal contamination, and abdominal trauma index. The incidence of infection was not statistically different among the groups. Enterobacteriacea were the predominant offenders, although anaerobes were identified in all groups. The critical risk factor was distal ileal or colon injury. This study indicates that a regimen employing a single agent whose spectrum includes both aerobes and anaerobes is as effective as more expensive and potentially toxic multiagent regimens.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6359913     DOI: 10.1016/0002-9610(83)90336-7

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  3 in total

Review 1.  Current management of colon trauma.

Authors:  Robert A Maxwell; Timothy C Fabian
Journal:  World J Surg       Date:  2003-05-02       Impact factor: 3.352

2.  Preventative antibiotics for penetrating abdominal trauma--single agent or combination therapy?

Authors:  B A Bivins; L Crots; V J Sorensen; F N Obeid; H M Horst
Journal:  Drugs       Date:  1988       Impact factor: 9.546

3.  Prophylactic antibiotics for penetrating abdominal trauma: duration of use and antibiotic choice.

Authors:  Philip J Herrod; Hannah Boyd-Carson; Brett Doleman; James Blackwell; John P Williams; Ashish Bhalla; Richard L Nelson; Samson Tou; Jon N Lund
Journal:  Cochrane Database Syst Rev       Date:  2019-12-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.